Product Information
LABETALOL HCL 200 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1421 per EA under NDC 68382079901. Its NADAC has been published 433 times since May 9, 2018.
FDA first approved this application on Sep 19, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382079901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207743FDA Approved
9/19/2017
TE Code
AB
On Market Since
12/5/2017
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 200 MG TABLET has been published 433 times since May 9, 2018, and over the history we have for it it has declined 41.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1421 per EA |
|---|---|
| All-time high | $0.2562 (Aug 15, 2018) |
| All-time low | $0.1222 (Nov 20, 2024) |
| 52-week high | $0.1481 |
| 52-week low | $0.1421 |
| Median price | $0.1738 |
| Average price | $0.1770 |
| Largest weekly change | -25.6% (Apr 17, 2024) |
| Weeks tracked | 433 |
| Tracking since | May 9, 2018 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LABETALOL HCL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 200 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1421 per EA (NDC 68382079901), effective Aug 19, 2026.
How has the price of LABETALOL HCL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 200 MG TABLET has declined 41.5%. It has been tracked across 433 weekly CMS publications since May 9, 2018.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 200 MG TABLET?
Since May 9, 2018, the NADAC for LABETALOL HCL 200 MG TABLET has ranged from a low of $0.1222 (Nov 20, 2024) to a high of $0.2562 (Aug 15, 2018), with a median of $0.1738 per EA.
Are there cheaper alternatives to LABETALOL HCL 200 MG TABLET?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LABETALOL HCL 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LABETALOL HCL 200 MG TABLET?
LABETALOL HCL 200 MG TABLET (NDC 68382079901) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.